Navigation Links
Nurse-Attorney/Former Bristol-Myers Squibb Executive Selected To Lead New Jersey State Nurses Association
Date:2/10/2010

TRENTON, N.J., Feb. 10 /PRNewswire/ -- The New Jersey State Nurses Association (NJSNA) today announced that Patricia A. Barnett, a nurse and attorney with three decades of public policy experience, has been selected as the new Chief Executive Officer of the Association by the Board of Directors. Barnett will begin her work at NJSNA on March 1st.  She replaces Dr. Barbara Wright, who has been serving as interim CEO following the retirement of longtime NJSNA CEO Andrea Aughenbaugh.

(Photo:  http://www.newscom.com/cgi-bin/prnh/20100210/PH52888 )

"We could not be more excited about the selection of Patricia to head our association," said Barbara Chamberlain, President of NJSNA. "Her skill-set and experience make her uniquely suited to lead NJSNA through what we are sure will be challenging times ahead in the rapidly changing world of health care."

Barnett served as Director and Government Affairs Manager for Bristol-Myers Squibb in Princeton from 1987 to 1993 and again in 1997 and 1998. She was Director of Economic and General Welfare for the Illinois Nurses Association in Chicago from 1979 until 1987. More recently, Barnett has served as Executive Director of Public Policy and Government Affairs for Forest Laboratories, Inc.

"I am thrilled to be given the opportunity to return to my roots and work exclusively on nursing issues," said Barnett. "I have 30 years experience impacting health policy and access to care at the city, state and federal level and I am eager to bring that experience to bear on behalf of New Jersey's 110,000 registered professional nurses."

A graduate of the Michael Reese Hospital School of Nursing, Roosevelt University and Loyola University School of Law, Barnett has served in both supervisory and line nursing capacities. She was a delegate to the American Nurses Association conventions in 1980 and 1982 and served on the Illinois Nurses Association Board of Directors.

"The quality of candidates we had seeking the Chief Executive Officer position was outstanding," added NJSNA's Institute for Nursing President, Dr. Mary Ann T. Donohue.  As Search Committee Chairman, Donohue expressed that "in Patricia Barnett, we believe we have found someone who will be a strong advocate for nurses statewide."

About NJSNA

New Jersey State Nurses Association (NJSNA) represents the interests of the state's 110,000 Registered Nurses, advances the profession of nursing and advocates on behalf of nurses and consumers. NJSNA, along with its national organization in Washington, DC, the American Nurses Association (ANA), and fifty- three state and territorial associations, all help to represent the nation's 2.6 million RNs. To learn more about NJSNA visit our website at www.NJSNA.org

Contact: Donald Sico 609-351-3591

SOURCE New Jersey State Nurses Association

RELATED LINKS
http://www.njsna.org

'/>"/>

SOURCE New Jersey State Nurses Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Bristol-Myers Squibb Announces Dividend
2. Jeremy Levin Joins Bristol-Myers Squibb as Senior Vice President of External Science, Technology and Licensing
3. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
4. Bristol-Myers Squibb to Announce Results for the Third Quarter of 2007 on October 25
5. Pharmacopeia Acquires Selective Androgen Receptor Modulator (SARM) Program from Bristol-Myers Squibb
6. ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan
7. Exelixis to Receive Milestone Payment From Bristol-Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone
8. Bristol-Myers Squibb Names Alan J. Lacy to Board of Directors
9. Avista Capital Partners Completes Acquisition of Bristol-Myers Squibb Medical Imaging
10. Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007
11. Bristol-Myers Squibb to Present at Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), an ... showcase a range of technology and learning solutions at the 68th Annual American ... to be held October 14–18, 2017 at the Mandalay Bay Resort in Las ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, ... a medical article to the newly revamped Cosmetic Town journal section, ... hair transplant procedure known as Follicular Unit Extraction (FUE). , Dr. ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand Rapids-based workplace ... Brightest in Wellness® by Best and Brightest. OnSite Wellness will be honored at ... from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... University of California Berkeley, and other leading institutions in announcing the launch of ... institutions to change the way animals are raised for food. , Founding members ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2017 The Rebound mobile app is poised to ... the tide of prescription drug addiction. The app empowers users ... and stepping down their dosage in a safe, controlled manner ... 2017; the first 100,000 people to sign up will enjoy ... ...
(Date:9/27/2017)... MIAMI , Sept. 27, 2017  Commended for their ... recent notable awards. Ranked as number one in the South ... ninth time in Inc. 5000 yearly list, the national specialty ... CEO, Armando Bardisa will soon be honored by ... Set to receive his award ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
Breaking Medicine Technology: